“The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men with Obesity and Insulin Resistance” (2026) Global Scientific Review, 48, pp. 42–45. Available at: https://scienticreview.com/index.php/gsr/article/view/602 (Accessed: 6 May 2026).